Clinical Trial Update: Riociguat in Scleroderma Associated Digital Ulcers [Phase 2]

View source ↗

Summary

A Phase 2 trial update on riociguat for digital ulcers associated with scleroderma has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digital Ulcers
• Systemic Sclerosis

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: Dinesh Khanna, MD, MS | Conditions: Scleroderma, Digital Ulcers | Phase 2 | Status: COMPLETED | Results posted: 2019-09-24